Daisy Wolf
Bio + Health

Daisy Wolf



More About Daisy

Daisy Wolf is an investing partner at Andreessen Horowitz, where she focuses on healthcare technology. In particular, she specializes in healthcare AI and software, consumer health, and the intersection of healthcare and fintech. Daisy is involved with companies like Honor, Marker Learning, Pomelo Care, Ribbon Health, and Season Health.

Prior to joining Andreessen Horowitz, Daisy worked at Meta in the Global Business Group, where she led company growth efforts within government and politics. In addition, Daisy has held various roles at multiple startups and covered technology at a hedge fund.

Daisy holds a JD from Yale Law School, an MBA from the Stanford Graduate School of Business, and a BA, Phi Beta Kappa from Yale College. Daisy is based in New York City and her interests include musical theater, political memoirs, and poker.

Latest Content

  • Longevity as a Health Asset with Tom Hale
    Tom Hale, Vijay Pande, Daisy Wolf, Kris Tatiossian, and Olivia Webb

    Tom Hale, CEO of ŌURA, joins Vijay Pande, founding partner, and Daisy Wolf, investment partner at a16z Bio + Health.

  • Metrics for a Complex Machine with Josh Clemente
    Josh Clemente, Vijay Pande, Kris Tatiossian, Olivia Webb, and Daisy Wolf

    Josh Clemente, cofounder and president of Levels, joins Vijay Pande, founding general partner, and Daisy Wolf, investment partner at a16z Bio + Health.

  • Transitioning from Gymnast to Investor with Aly Raisman
    Aly Raisman, Kris Tatiossian, Olivia Webb, Daisy Wolf, and Julie Yoo

    Former gymnast and current investor Aly Raisman joins general partner Julie Yoo and investment partner Daisy Wolf of a16z Bio + Health.

  • Underestimating AI in Healthcare
    Daisy Wolf, Adela Tomsejova, Jay Rughani, and Vijay Pande

    100% of stock trades used to be made by humans. Today, 80% are made by computer algorithms. AI is about to bring a similar revolution to healthcare. Over the next few decades, at least half of the $4.3 trillion dollar American healthcare industry will be AI-driven.

  • While the Google --> WebMD --> Friend protocol may be a common way to enter into the healthcare system, it is certainly not an optimal one. Most of us are not well-equipped to self-diagnose from a list of possible conditions, and our friends who work in healthcare often don’t have the exact expertise we need.

Load More
go to top